Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01425515 · ClinicalTrials.gov registry record · NA
Improving Care for Patients With High Blood Pressure
A NA study of Hypertension and Cardiovascular Disease Risk, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 535
- Enrollment target
- 1
- Study location
NCT01425515: Completed NA study of Hypertension and Cardiovascular Disease Risk, sponsored by University of North Carolina, Chapel Hill.
NCT01425515 is a NA study of Hypertension and Cardiovascular Disease Risk that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 535 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01425515, a NA study of Hypertension and Cardiovascular Disease Risk, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 535 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are conducting a single group intervention study to improve blood pressure control and reduce racial and literacy related disparities among people with hypertension. The intervention includes providing patients with home blood pressure monitors, administering phone-coaching to participants, and improving hypertension care at the participating practices from which patients are enrolled. The investigators will follow the patients for 2 years to determine if blood pressure control improves. In addition, the project will explore genetic factors associated with cardiovascular disease risk and treatment success.
Primary Outcome
We will measures blood pressure at enrollment and then every 6 months for 24 months.
Conditions Studied
Interventions
- BEHAVIORAL Complex quality improvement intervention
Study Locations (1)
North Carolina
- Kinston Enterprise Center - Study Office - Kinston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 535 participants |
| Start Date | 2011-09 |
| Est. Completion | 2014-10 |
| Phase | NA |
What the finished NCT01425515 record still lists
NCT01425515 is an interventional study that assigns participants to a tested intervention. The registered 535 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Complex quality improvement intervention is the first listed.
NCT01425515 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01425515 about?
NCT01425515 is a clinical study titled "Improving Care for Patients With High Blood Pressure". The investigators are conducting a single group intervention study to improve blood pressure control and reduce racial and literacy related disparities among people with hypertension. The intervention includes providing patients with home blood pressure monitors, administering phone-coaching to part...
What is the current status of trial NCT01425515?
This trial is currently completed. It is a NA study. The enrollment target is 535 participants. The study started on 2011-09. Estimated completion is 2014-10.
What conditions does trial NCT01425515 study?
This clinical trial studies the following conditions: Hypertension, Cardiovascular Disease Risk.
What interventions are being tested in trial NCT01425515?
The interventions under investigation include: Complex quality improvement intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01425515?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01425515 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01425515's enrollment target sits among peer trials
535 113th of 470 higher than 358 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05614739 · 535 participants · Phase 1
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
- NCT07091617 · 535 participants · NA
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
- NCT04910685 · 534 participants · Phase 2
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
- NCT06128551 · 534 participants · Phase 1
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia